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Abstract
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Achieving the vision of identifying and quantifying cancer-related events and targets for future
personalized oncology is predicated on the existence of synthetically accessible and economically
viable probe molecules fully able to report the presence of these events and targets in a rapid, and
highly selective and sensitive fashion. Delineated here are the design and evaluation of a newly
synthesized turn-on probe whose intense fluorescent reporter signature is revealed only through
probe activation by a specific intracellular enzyme present in tumor cells of multiple origins.
Quenching of molecular probe fluorescence is achieved through unique photo-induced electron
transfer (PeT) between the naphthalimide dye reporter and a covalently attached, quinone-based
enzyme substrate. Fluorescence of the reporter dye is turned on by rapid removal of the quinone
quencher, an event that immediately occurs only after highly selective, two-electron reduction of
the sterically and conformationally restricted quinone substrate by the cancer-associated human
NAD(P)H:quinone oxidoreductase isozyme 1 (hNQO1). Successes of the approach include rapid
differentiation of NQO1-expressing and non-expressing cancer cell lines via the unaided eye, flow
cytometry, fluorescence imaging, and two-photon microscopy. The potential for use of the turn-on
probe in longer-term cellular studies is indicated by its lack of influence on cell viability and its in
vitro stability.
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INTRODUCTION
Molecular probes whose fluorescent reporter signal is generated (turn-on probes) by enzyme
activation1 hold great potential for identification, enumeration, and study of living cancer
cells—outcomes invaluable for accurate and early diagnoses and optimization of surgical
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and personalized chemotherapeutic treatments.2,3 In particular, the successful development
of enzyme-activatable probes that can yield rapid, and highly sensitive and selective,
reporting of species or events associated with cancer cells4–6 will allow for definition of
diseased and healthy tissue borders during fluorescence-assisted surgical resection of
cancerous tissues and collection of real-time information on tumor cell microenvironment or
the pharmacodynamic effect of drugs on specific tumor cells.3,5–13 To date, live cancer cell
detection with varying degrees of selectivity and sensitivity has been limited to routes
employing extracellular or cell-surface protein recognition of a covalently attached
component of the probe or reporter.3,12,14 However, successful identification of living
cancer cells and their type differentiation can be achieved by targeting endogenous,
intracellular, cancer-associated enzymes with hydrophobic small-molecule (<1000 Da),
turn-on probes, an outcome not possible with large-molecule, recognition-based probes.
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A potentially significant and unexplored route with turn-on probes for diagnostics is that in
which selectivity and sensitivity of the target reporting process are controlled by
enzymatically stimulated removal of fluorescence quencher from the probe. In particular,
this route employs probes whose reporter fluorescence is quenched by photo-induced
electron transfer (PeT)15 from a covalently attached enzyme substrate. Fluorescence ensues
from the reporter upon removal of the quencher substrate by an endogenous, cytosolic,
disease-associated enzyme found in diseased cells from a wide range of origins.
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NAD(P)H:quinone oxidoreductase isozyme 1 (NQO1)16–19 is intimately involved with
cancer, as it is a gatekeeper for the 20S proteasomal degradation of the p53, p73α, and p33
tumor suppressors16 and is present in a diverse group of human tumor cells (e.g., pancreas,
colon, breast, lung, liver, stomach, kidney, head/neck, and ovaries) at levels 2- to 50-fold
greater than in normal tissue.17 Furthermore, NQO1 content/activity in tumor cells is
strongly affected by cell life cycle and therapeutic approaches.18–20 Importantly, NQO1 is
found in the cytosol and catalyzes the strict two-electron reduction of quinones to
hydroquinones, making this flavoenzyme an ideal target for pro-drug therapies21 and profluorophores.
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Herein we report the design, properties, and NQO1-specific cellular activation of a firstgeneration, PeT-quenched fluorescence probe. The turn-on sensor probe readily penetrates
the membrane of human cancer cells, because it is hydrophobic, small in molecular weight,
and charge neutral. Upon rapid and preferential, two-electron reduction of the quinone
quencher subunit of the turn-on probe, an intensely light-emissive reporter results from
autonomous removal of the activated quinone subunit. Efficacious PeT quenching of
fluorescence prior to subunit self cleavage is ensured by careful selection of the electronic
properties of the naphthalimide reporter and quinone quencher. The resulting highly
fluorescent, cationic reporter is retained by cells, and it exhibits a strong Stokes shift
between its absorption and fluorescence emission maxima due to the push-pull internal
charge transfer mechanism associated with the naphthalimide scaffold. Overall, these probe
characteristics allow for rapid and enhanced signal-to-background imaging and detection of
living cancer cells without the typical requirement of unactivated probe removal from the
environment. In total, the pro-fluorogenic probe provides for real-time, highly sensitive and
selective human tumor cell analysis and differentiation based on NQO1 content.
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RESULTS AND DISCUSSION
Q3NI Probe Fluorescence is Controlled by Photo-induced Electron Transfer (PeT)
Quenching
We designed the Q3NI probe to have the fluorescence signal of its naphthalimide
reporter22,23 quenched via oxidative electron-transfer (OeT) by the covalently attached
quinone propionic acid motif, Figure 1A. It was posited that it would be possible to achieve
this novel mechanism of reporter quenching by carefully tuning the electronic and optical
properties of the quinone OeT quencher and the naphthalimide reporter NI, due to extant
naphthalimide reporters that are quenched by reductive electron-transfer (ReT).22 The
Rehm-Weller equation, Equation 1,
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(1)
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was used to examine possible quinone propionic acid quenchers24 and 1,8-naphthalimide
reporters, as well as linkers between the OeT quencher and the NI reporter, so as to ensure
that quenching is thermodynamically feasible and efficient.15 In this equation, ED is the
redox potential of the donor and EA that of the acceptor, ΔG00 is the energy of the first
excited singlet state of the reporter, and e2/εd is the Coulombic interaction energy of the ion
pair, known to be 0.06 eV.15 The energy of the first excited singlet state of NI was measured
to be 3.06 eV.15 From voltammetric measurements, ED of NI was determined to be 1.74 V,
and EA for the quinone propionic acid group of Q3NI was found to be −1.01 V (Figure S2).
From these values, the energy change for this OeT process, ΔGPeT, is calculated to be −0.37
eV, indicating that electron transfer from the excited dye to the electron-poor quinone is
thermodynamically favorable. The quinone was attached to the naphthalimide via an Nmethylethanolamine linker through a carbamate to the amine of the naphthalimide ring. This
linker imparts three crucial properties on Q3NI: the linker is sufficiently short to allow for a
high probability of electron transfer, the electron-withdrawing carbamate yields a favorable
ΔGPeT, and the presence of the tertiary amide provides enhanced environmental
stability.23,25 As a result, the fluorescence of Q3NI in pH 7.4, 0.1 M PBS is effectively
quenched in comparison to that of the free NI reporter, as noted by their spectra in Figure
1B and 1C and respective fluorescence quantum yields (Φ) of 0.007 and 0.23 obtained using
quinine sulfate as standard.26 The quantum yield for NI is superior or comparable to that of
other dyes applied to cancer detection and localization, such as Φ = 0.0028 for indocyanine
green and Φ = 0.21 for Cy5.5 dyes.13,27 The 33-fold fluorescence enhancement for NI
versus Q3NI and very large Stokes shift of 116 nm (λmax, abs = 374 nm, λmax, em = 490 nm)
bode well for use of Q3NI as a multifunctional turn-on probe for sensing and imaging
applications that utilize reductive stimuli capable of initiating removal of the reduced
quinone group.28–31
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Fluorescence Dequenching of Q3NI is Achieved by Reduction-initiated Removal of
Quinone
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We then wished to determine if it is possible to produce the NI reporter from the Q3NI
probe by the expected cyclizative cleavage reaction of the hydroquinone via the gem-dialkyl
effect32 that occurs subsequent to two-electron reduction of the quinone.28 Thus, the strong
reducing agent sodium dithionite was added to aqueous solutions of Q3NI. Under these
conditions, it was found that NI is rapidly released as indicated by the increase in timedependent fluorescence intensity (Figure 2) at 470 nm (λex = 370 nm). To provide proof
positive that the increase in fluorescence for reduced Q3NI results from cyclizative cleavage
of the hydroquinone reduction product as the lactone, a second probe (Q1NI) was
synthesized such that the rate of lactone formation from its hydroquinone form is >103 times
slower than in the case of reduced Q3NI, due to the lack of the two methyl groups on the
geminal carbon.28 Dithionite reduction of the Q1 group is known to be equally fast as the Q3
group.28 As seen in Figure 2, reduced Q3NI exhibits exceedingly rapid NI reporter
production in comparison to reduced Q1NI; at 37 min (the maximum recorded for Q3NI),
the signal for reduced Q3NI is 20-fold higher than that for Q1NI. Although it could be
argued the signal for reduced Q3NI is attributable to the absence of photo-induced electron
transfer quenching of the reporter by the hydroquinone of Q3NI, a significantly favorable
ΔGPeT of −3.37 eV for the reductive quenching process of the NI reporter by the
hydroquinone clearly supports its occurrence. That is, once the quinone is reduced to its
hydroquinone (HQ3NI, Figure 1A), quenching of reporter fluorescence occurs by reductive
electron transfer (ReT), a common feature with naphthalimide dyes.22 Furthermore, we have
isolated and identified the NI reporter from Q3NI solutions treated with dithionite (Figure
S-6). Thus, the rapid increase in fluorescence for reduced Q3NI results from naphthalimide
dequenching caused by reduction-initiated removal of the quinone propionic acid group by
lactonization. Due to the unique quenching mechanism of the Q3NI turn-on probe sensor,
pronounced fluorescence signal enhancement upon revealing the NI reporter and its large
Stokes shift, and the known resistance of the quinone propionic acid trigger group to
reduction by other biological species,31 we investigated Q3NI as a sensor probe of human
NAD(P)H:quinone oxidoreductase isozyme 1 (hNQO1) activity in real-time biological
applications.
Q3NI is Activated by hNQO1 at a High Rate
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We determined if Q3NI is a substrate capable of activation by hNQO1 to yield the NI
reporter at a significant rate. To do so, we obtained the apparent kinetic parameters from
Michaelis-Menten kinetic treatment33 of the time-dependent NI reporter production, namely
the Michaelis constant (Km), maximum velocity (Vmax), catalytic constant (kcat), and
substrate specificity (kcat/Km). The high rate of NI reporter production under in vitro
conditions is readily apparent in the inset of Figure 3; after 5 min, a fluorescent signal has
been attained that is 22% of the maximum achievable, yielding 2.2 × 10−7 M of released
reporter. From the plot shown in Figure 3, we obtained Km = 3.86 ± 0.79 μM, Vmax = 0.037
± 0.002 μmol min−1mg · NQO1−1, kcat = 0.019 ± 0.001 s−1, and kcat/Km = 4.94 ± 0.33 × 103
M−1s−1. Due to the presence of the non-bulky ethanolamine linker and the need of only a
single activation step to reveal reporter fluorescence, the kinetic constants are significantly
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higher than those of other NQO1 activatable fluorophores,31,34,35 thereby ensuring sufficient
signal enhancement for fast detection of hNQO1 activity.
Cancer Cells can be Rapidly Visualized and Differentiated Based on hNQO1 Activation of
Q3NI

Author Manuscript

Our interest in the potential use of the Q3NI probe in microfluidic-based cell sorting/
isolation of circulating tumor cells36 and fluorescence-guided resection of tumors3 led us to
evaluate if the Q3NI probe can be used to discriminate between cancer cells of different
origins and hNQO1 content, with and without the aid of sophisticated instrumentation. The
colorectal carcinoma cell line HT-29 and the non-small cell lung cancer (NSCLC) A549 cell
line are known to possess significant hNQO1 activity, while the NSCLC H596 cell line has
been reported to have undetectable hNQO1 activity.37,38 After a 10-min incubation period in
a cell culture solution containing 2 × 10−5 M Q3NI, it was possible to differentiate between
the various substrate-cultured cells (4.84 cm2) using only a hand-held fluorescent lamp
emitting at 365 nm and the un-aided eye (Figure 4). Both HT-29 (3.69 × 106 total cells) and
A549 (5.72 × 106 total cells) appeared fluorescent blue, while H596 (3.96 × 106 total cells)
exhibited no apparent emission. The ability to visually determine the presence of hNQO1 in
a small number of cells is due to the marked difference in fluorescence from the unquenched
NI reporter (Φ = 0.23) and quenched Q3NI probe (Φ =0.007) and the large Stokes shift of
the NI reporter that results in fluorescence emission in the visible spectrum (400 nm to ~600
nm). These outcomes point to potential use of the Q3NI probe sensor in the real-time,
visible (without the aid of imaging equipment) and accurate determination of tumor/healthy
tissue borders so as to allow for surgical resection of tumors with small foci.
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Flow cytometry assays (Figure 5) were used to assess the applicability of the Q3NI probe to
rapidly detect and quantify tumor cells containing hNQO1. The probe was incubated in a
suspension of HT-29, A549, H596, and H446 (a small cell lung carcinoma known to be
devoid of hNQO1 activity37) cells for either 10 or 60 min, and a flow cytometer was used to
measure the fluorescence (λex = 405 nm, λem = 457/60 nm) in 10,000 individual cells. In
Figure 5 are shown the histograms for each cancer cell line. It is clear that a high-intensity,
unimodal distribution of signals is obtained for Q3NI activation in each of the two hNQO1positive cell lines (HT-29 and A549), while the negative cell lines H596 and H446 produced
minimal fluorescence. It was also found that there was little change in the cell count or
intensity of the histograms for a longer probe incubation time (60 min vs. 10 min, Figure
S3), demonstrating the rapid and substantial activation of Q3NI in A549 and HT-29 cells.
Importantly, the sustained low fluorescence observed with the H446 cells (Figure S3) points
to the intracellular stability of Q3NI (lack of non-specific activation). Thus, it is indicated
that Q3NI is a highly sensitive and selective probe capable of being used to rapidly discern
different types of tumor cells in fluidic streams.
Live and Fixed hNQO1-containing Cancer Cells can be Selectively Imaged via Q3NI
Activation
We desired to know if cancer cell types can be differentiated in conventional fluorescence
microscopy images resulting from Q3NI activation by hNQO1, and if it is possible to obtain
images that allow collection of information regarding the fate of the released NI reporter.
J Am Chem Soc. Author manuscript; available in PMC 2016 January 06.
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Furthermore, we wished to learn if the NI reporter can be successfully used in upconversion
fluorescence (multi-photon) imaging of live cells.13 In agreement with flow cytometry data,
wide-field imaging of fixed hNQO1-positive cells exposed to the Q3NI probe for 10 min
revealed significant probe uptake and activation that leads to intracellular NI fluorescence
for the A549 and HT-29 cell lines; however, minimal signal was observed in the hNQO1negative H596 cells (Figure S4). There was no indication of reporter in the nucleus, pointing
to the lack of NQO1 there; this is in clear contrast to previous work using
immunohistochemical staining of permeabilized, fixed cells.39 The average cytosolic signal
was 9 times higher in A549 cells versus NQO1-negative H596 cells, while it was 23 times
higher in HT-29 cells compared to the NQO1-negative H596 cells. After incubating live
HT-29 cells for 20 min with Q3NI followed by exposure to acidic organelle-specific
Lysotracker Red in the media in the imaging dish, it was found that the majority of the NI
signal originated from the cytosolic region. Not surprisingly, accumulation of the basic
(secondary amine pKa ~11) NI occurred in acidic late endosomal and lysosomal vesicles
(Figure S5), a beneficial outcome that leads to enhanced intracellular retention of NI. The
higher signal-to-background value achieved for activation of Q3NI to NI reporter (9- to 23fold) in target versus non-target cells, relative to that of other exogenously introduced sensor
probes for whole tumor analysis (2.5- to 5-fold),40–42 points to the potential of Q3NI to
provide highly selective tumor cell analyses with low limits of detection, even in the face of
possible background fluorescence from hemoglobin and other species.1 In addition, our
results indicate that dye quantum yield is affected little, and there is no apparent efflux of NI
reporter from cells during paraformaldehyde fixing, as noted by sustained fluorescence in
fixed samples stored for 10 months in the laboratory ambient. Collectively, there is great
potential for use of our probe/reporter system for ex vivo quantitative analysis of excised
tumor cells and long-term in vivo and in vitro imaging.
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Multiphoton (MP) microscopy imaging of cells and tissues is more advantageous when
compared to traditional fluorescence microscopy, because use of the characteristic longwavelength photons offers higher fluorophore and cellular photostability that provides
extended imaging duration, less background signal from out-of-focus excitation and
scattering events, and deeper penetration depth. In addition, MP imaging is ideal for direct
observation of targets in their physiological environment and ex vivo thick-specimen
sampling where 2D and 3D maps can be generated.13 During incubation with complete
growth medium containing 2.0 × 10−5 M Q3NI, 2-photon microscopy revealed significant
fluorescence signal from NI in living, hNQO1-positive HT-29 and A549 cells (Figure 6) and
minimal signal in two living, hNQO1-negative cell lines, H596 and H446. The average
fluorescence signal was determined to be 13-fold higher in A549 cells compared to H596
cells, and 3.66 × 104-fold higher versus H446 cells. Similar results were obtained with the
HT-29 cell line, with the cytosolic intensity being 15- and 4.51 × 104-fold higher compared
to H596 and H446 cells. As before, the signal appears somewhat heterogeneous throughout
the cytosolic space of the HT-29 and A549 cells due to NI accumulation in acidic
organelles. To ensure Q3NI and NI had little effect on cell health, cells were incubated in a
2.0 × 10−5 M Q3NI solution in complete growth medium for one hour and one day, and then
cell viability was assessed with a trypan blue assay. After 1 h, cell viability for HT-29,
A549, and H596 was 97.7%, 98.8%, and 100%, while it was 97.7%, 98.7%, and 98.4% after
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24 h. Of particular importance is the real-time nature of the Q3NI probe in imaging, as this
system does not require the time-consuming wash steps characteristic of always-on
reporters.1,4

CONCLUDING REMARKS
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In summary, we have presented the successful development and implementation of a
quenched turn-on probe whose fluorescent reporter signal is selectively and quickly
generated and maintained in human cancer cells upon activation by a cancer-associatedenzyme substrate that is subsequently removed from the probe to yield the free de-quenched
reporter dye. Specifically, intracellular reduction of the quinone substrate by
NAD(P)H:quinone oxidoreductase and successive self-removal of the reduced substrate
from the reporter leads to elimination of the photo-induced electron-transfer quenching
event, thereby yielding the naphthalimide reporter possessing a highly intense and Stokesshifted emission. As a result, we have achieved rapid and highly selective/sensitive
detection, differentiation, and enumeration of cancer cells in flowing streams and under
traditional microscopy conditions without the use of recognition agents, an outcome that has
in turn allowed for imaging of live cancer cells by multi-photon fluorescence microscopy.
The latter outcome bodes well for in vivo and ex vivo thick-specimen imaging, where the
efficacy of treatment protocols and the cellular impact of pharmaceutical targets can be
evaluated for personalized oncology. Finally, control over the emission characteristics of the
reporter dye22 coupled to our ability to visibly see, by the un-aided eye, relatively small
numbers of cancer cells, reveals the potential of this new class of probes for application to
fluorescence-guided surgical resection of cancerous tissues.
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EXPERIMENTAL
Full details regarding materials, synthesis of compounds, and their characterization are
described in the Supporting Information.
Cell Culture
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HT-29 (human colorectal adenocarcinoma), A549 (human non-small cell lung cancer,
NSCLC), H596 (human NSCLC), and H446 (human small-cell lung cancer) were all
purchased from American Type Cell Culture. HT-29 cells were cultured in McCoy’s 5A
medium supplemented with 10% fetal bovine serum (FBS) and 100 IU/mL penicillinstreptomycin, A549 cells were cultured in F-12K medium with 10% FBS and 100 IU/mL
penicillin-streptomycin, and H596/H446 were cultured in RPMI-1640 with 10% FBS and
100 IU/mL penicillin-streptomycin. Cells were incubated at 37 °C in a humidified incubator
containing 5% wt/vol CO2.
Flow Cytometry
To a 1-mL suspension of cells (1 × 106) in complete growth medium was added Q3NI from
a stock dimethylsulfoxide (DMSO) solution to give a final [Q3NI] = 2 × 10 −5 M and
[DMSO] ~1%. After 10- or 60-min incubations at 37 °C, the cells were fixed with 30 mL of
4% paraformaldehyde in 0.1 M PBS for 1 h, followed by washing twice with 0.1 M PBS,
and then resuspending in 1 mL PBS. Data acquisition was carried out on an iCyt Reflection
J Am Chem Soc. Author manuscript; available in PMC 2016 January 06.
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flow cytometer using 405-nm excitation and a 457/60 nm emission filter; logarithmic
amplification was used. Winlist software (Verity Software House, Topshame, ME) was used
to count 10,000 cells per sample; FlowJo software was used to construct histograms.
Enzyme Kinetics
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All fluorescence measurements (λex = 390 nm, λem = 470 nm) were obtained at room
temperature, with solutions composed of pH 7.4, 0.1 M PBS/0.1 M KCl/0.007% BSA. A
stock solution of 1 × 10 −4 M β-nicotinamide adenine dinucleotide, reduced disodium salt
(NADH, Sigma-Aldrich), was made with the PBS buffer; this NADH solution was
subsequently used to prepare all other solutions so as to have a final concentration of 1 ×
10 −4 M β-NADH in each assay. Solutions consisting of 2 × 10 −6 to 6 × 10 −5 M Q3NI were
made using the NADH stock. A 1.33 μg/mL stock solution of recombinant human NQO1
(Sigma-Aldrich) was prepared using the same buffer as above so as to give 2.0 × 10−5 g
hNQO1 per assay. Each assay was performed in a quartz fluorescence cuvette containing 1.5
mL Q3NI solution and initiated by the addition of 1.5 mL hNQO1 solution. Measurements
were collected every 30 s for 5 min. Fluorescence units were converted to concentration by
relating the signal increase to a fluorescence signal derived from a known concentration of
NI. Plots of velocity versus Q3NI concentration were used to obtain apparent Km and Vmax
values from non-linear least squares analysis employing algorithms developed by Cleland
for Michaelis-Menten kinetics.33
Cell Viability
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Cells were cultured in 5 mL of complete growth medium in a sterile tube. To the medium
was added Q3NI (from a 1.8 × 10−3 M stock solution) in DMSO, to give a 2.0 × 10−5 M
Q3NI solution, and the cells were incubated at 37 °C, 5% CO2 for 1 h or 24 h, after which 1
mL of the cell suspension was removed and then 0.1 mL trypan blue was added. Cells were
immediately counted using a hemocytometer and microscope.
Optical Differentiation
HT-29, A549, and H596 cells were cultured overnight on 2.2 × 2.2 cm glass cover slips. Old
growth medium was removed and replaced with a 2.0 × 10−5 M Q3NI solution in fresh
growth medium. Cells were incubated at 37 °C with Q3NI for 10 min and then rinsed with
0.1 M PBS. Cover slips of each cell line were immediately placed upside down on glass
slides and visualized with a Kodak digital camera in conjunction with a Mineralight Model
UVGL-25 lamp (365 nm, 0.16 amps, 60 Hz).
Confocal Colocalization
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Confocal fluorescence images were acquired with a Leica TCS SP5 tandem scanning
multiphoton laser scanning microscope using a 40x oil immersion objective lens (1.25 NA).
Imaging of Lysotracker Red- and Q3NI-exposed cells was accomplished using a sequential
scanning method with λex = 405 nm at 10% output and collecting emission between 417 and
467 nm (Q3NI) or λex = 561 nm at 10% output, and the emitted light was collected between
574 and 621 nm (Lysotracker Red). Differential interference contrast (DIC) images were
obtained using a PMT detector and 633-nm light at 3% output as an illumination source. All
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images were collected at 37 °C using the Leica TCS SP5 in resonant scanning mode (16
KHz) at a zoom setting of 3.6. Images were line averaged 64 times. Cells were cultured
overnight in black 35 × 10 mm, 22-mm well, glass-bottom dishes (Chemglass Life
Sciences). Prior to imaging, the medium was removed and replaced with medium
(containing no phenol red) and maintained at 37 °C. A concentrated solution of Q3NI in
DMSO was added directly to the dish to give a concentration of 2.0 × 10−5 M, with [DMSO]
≤ 1%. Cells were incubated with Q3NI for 20 min. Five min prior to imaging, Lysotracker
Red-DND 99 in DMSO was added to give a concentration of 1 × 10−7 M.
In vitro 2-Photon Imaging
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Two-photon confocal fluorescence images were acquired as above using a MaiTai twophoton laser tuned to 750 nm (3% laser power, modelocked Ti:sapphire laser; Tsunami
Spectra Physics), and emission was collected using a short-pass 680-nm filter. DIC images
were collected as above. Cells were imaged, with no washing or medium removal steps,
after a 10-min incubation with Q3NI. Image analysis was performed in ImageJ.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Author Manuscript

Schematic representation of the unique utilization of PeT quenching in the hNQO1 probe
Q3NI and the emission properties associated with Q3NI probe and NI: (A) proposed
quenching mechanisms for Q3NI probe prior to and after chemical/hNQO1-catalyzed
reduction, and subsequent production of the fluorescent NI reporter. Fluorescence spectra
and optical images of cuvettes containing 2.0 × −6 M solutions of (B) Q3NI probe and (C)
NI reporter in pH 7.4, 0.1 M PBS that result from excitation at λex = 375 nm (spectra) and
λex = 365 nm (images).
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Figure 2.
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Comparing the dithionite-initiated formation of NI reporter from Q3NI probe and Q1NI.
The fluorescence (λex = 370 nm, λem = 470 nm) from 3-mL solutions of 1.0 × 10−5 M Q3NI
probe and Q1NI in pH 7.4, 0.1 M PBS was monitored after their reduction by addition of
2.75 mg sodium dithionite (denoted by arrow).
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Figure 3.

Author Manuscript

Kinetics plot of hNQO1 (2.0 × 10−5 g) toward Q3NI Probe. Inset is an example of an assay
observing fluorescent NI production from 1 × 10−6 M Q3NI, relative to signal for complete
NI formation (1 × 10−6 M). Values (n = 3) are the average ± 1 standard deviation.
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Figure 4.

Visual differentiation of (A) HT-29, (B) A549, and (C) H596 cancer cells cultured on 2.2 ×
2.2 cm glass substrates after 10-min incubation with 2 × 10−5 M Q3NI probe. Images of
cells were captured with a digital camera upon irradiation at λex = 365 nm with a hand-held
lamp. Scale bar represents 1 cm.
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Figure 5.
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Flow cytometry assays of Q3NI activation by hNQO1-positive (A549 and HT-29) and
hNQO1-negative (H596 and H446) cancer cells. Assays were performed by counting 10,000
cells that had been exposed to 2.0 × 10−5 M Q3NI probe for 10 min; λex = 405 nm, λem =
457/60 nm.
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Figure 6.

Two-photon confocal microscopy imaging of living HT-29 (A,E), A549 (B,F), H596 (C,G),
and H446 (D,H) cells in the presence of 2.0 × 10−5 M Q3NI probe. Fluorescence images of
each cell line are on the top row with their respective differential interference contrast (DIC)
image on the bottom row. Images were acquired at λex = 750 nm (3% laser power) without
any washing steps between Q3NI probe addition and imaging. Scale bars represent 2.5 ×
10−5 m.
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